PharmGen Science Inc (004720) — Net Asset Quality Index
PharmGen Science Inc (004720) has a Net Asset Quality Index of 74.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩331.46 Billion minus total liabilities of ₩83.70 Billion yields net assets of ₩247.76 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See PharmGen Science Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
PharmGen Science Inc Net Asset Quality Index Over Time (2004–2024)
This chart shows how PharmGen Science Inc's Net Asset Quality Index has evolved across 17 annual periods from 2004 to 2024. As of September 2025, the index stands at 74.7%, representing net assets of ₩247.76 Billion against total assets of ₩331.46 Billion KRW. Explore cash flow conversion of PharmGen Science Inc to assess how effectively this company generates cash.
Annual Net Asset Quality Index for PharmGen Science Inc (2004–2024)
The table below presents the year-by-year Net Asset Quality Index for PharmGen Science Inc from 2004 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 004720 stock market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 68.6% | ₩249.43 Billion | ₩363.45 Billion | ₩114.02 Billion | ▲ +0.7 pp |
| 2023 | 67.9% | ₩228.21 Billion | ₩335.92 Billion | ₩107.71 Billion | ▲ +2.7 pp |
| 2022 | 65.3% | ₩207.12 Billion | ₩317.39 Billion | ₩110.28 Billion | ▲ +7.6 pp |
| 2021 | 57.6% | ₩126.93 Billion | ₩220.32 Billion | ₩93.39 Billion | ▼ -4.0 pp |
| 2020 | 61.7% | ₩83.57 Billion | ₩135.54 Billion | ₩51.97 Billion | ▲ +5.4 pp |
| 2019 | 56.2% | ₩56.25 Billion | ₩100.03 Billion | ₩43.79 Billion | ▼ -1.7 pp |
| 2018 | 57.9% | ₩56.85 Billion | ₩98.19 Billion | ₩41.35 Billion | ▼ -16.7 pp |
| 2017 | 74.6% | ₩51.05 Billion | ₩68.48 Billion | ₩17.43 Billion | ▲ +17.9 pp |
| 2016 | 56.6% | ₩36.41 Billion | ₩64.30 Billion | ₩27.89 Billion | ▼ -5.1 pp |
| 2015 | 61.7% | ₩28.66 Billion | ₩46.45 Billion | ₩17.79 Billion | ▲ +13.9 pp |
| 2014 | 47.8% | ₩20.12 Billion | ₩42.04 Billion | ₩21.93 Billion | ▼ -12.8 pp |
| 2013 | 60.6% | ₩23.83 Billion | ₩39.33 Billion | ₩15.49 Billion | ▼ -0.2 pp |
| 2012 | 60.8% | ₩25.90 Billion | ₩42.61 Billion | ₩16.71 Billion | ▲ +17.1 pp |
| 2011 | 43.6% | ₩18.69 Billion | ₩42.82 Billion | ₩24.13 Billion | ▼ -6.1 pp |
| 2005 | 49.8% | ₩33.07 Billion | ₩66.47 Billion | ₩33.40 Billion | ▼ -0.6 pp |
| 2004 | 50.3% | ₩24.91 Billion | ₩49.49 Billion | ₩24.58 Billion | ▼ -1.2 pp |
| 2004 | 51.6% | ₩25.73 Billion | ₩49.90 Billion | ₩24.17 Billion | — |